tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Shenzhen Hepalink to Review Interim Results and Consider Dividend
PremiumCompany AnnouncementsShenzhen Hepalink to Review Interim Results and Consider Dividend
4M ago
Shenzhen Hepalink Advances H1710 Injection to Phase I Clinical Trial
Premium
Company Announcements
Shenzhen Hepalink Advances H1710 Injection to Phase I Clinical Trial
5M ago
Shenzhen Hepalink Announces Final Dividend for 2024
Premium
Company Announcements
Shenzhen Hepalink Announces Final Dividend for 2024
5M ago
Shenzhen Hepalink Releases 2025 Q1 Financial Report
PremiumCompany AnnouncementsShenzhen Hepalink Releases 2025 Q1 Financial Report
7M ago
Shenzhen Hepalink’s Ivenoxin Gains Approval for South African Market
Premium
Company Announcements
Shenzhen Hepalink’s Ivenoxin Gains Approval for South African Market
7M ago
Shenzhen Hepalink Schedules Board Meeting for Q1 Results
Premium
Company Announcements
Shenzhen Hepalink Schedules Board Meeting for Q1 Results
8M ago
Shenzhen Hepalink to Approve Annual Results and Consider Dividend
PremiumCompany AnnouncementsShenzhen Hepalink to Approve Annual Results and Consider Dividend
9M ago
Shenzhen Hepalink’s Enoparin Gains Approval in Argentina, Boosting Global Expansion
Premium
Company Announcements
Shenzhen Hepalink’s Enoparin Gains Approval in Argentina, Boosting Global Expansion
9M ago
Shenzhen Hepalink Receives Approval for Clinical Trial of New Cancer Drug
Premium
Company Announcements
Shenzhen Hepalink Receives Approval for Clinical Trial of New Cancer Drug
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100